Computational biologist Jinghui Zhang of St. Jude realized scientists could work more efficiently with tools and genomic data shared on the cloud.

An artificially intelligent program tracks the motion of infants to help doctors look for links to disorders with abnormal motions.

The publication of the SCIPIO trial is among many by Piero Anversa’s lab that Harvard Medical School flagged for fraudulent data.

Uncertainties about the cells’ risk profiles and the potential for hyping unproven therapies mean scientists and the media must tread carefully.

The “London patient” may represent the second person cured of the infection by a cell transplant.

The treatment will be tested in a handful of patients who suffered nerve damage in sports or traffic accidents.

Two studies show signs that the introduced DNA is functioning, but it’s too early to know if patients actually benefit.

An enzyme of the bacteria Porphyromonas gingivalis has been found in the brains of patients with the disorder, and causes neurodegeneration in mice.

Results from an observational study find that the introduction of a routine vaccine in Australia coincided with a fall in the incidence of the autoimmune condition.